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Abstract
Background: Different definitions of constipation have been used to estimate its prevalence in the community but
this creates difficulties when comparing results from various studies. This study explores the impact of different
definitions on prevalence estimates in the same population and compares the performance of simple definitions
with the Rome III criteria.
Methods: The prevalence of constipation in a large nationally representative sample of community-dwelling adults
was estimated using five simple definitions of constipation and compared with definitions based on the Rome III
criteria. The sensitivity, specificity, and positive and negative predictive values, were calculated for each definition
using the Rome III criteria as the gold standards for chronic and sub-chronic constipation.
Results: Prevalence estimates for the five simple definitions ranged from 9.4 to 58.9%, while the prevalence
estimates using the Rome III criteria were 24.0% (95%CI: 22.1, 25.9) for chronic constipation and 39.6% (95%CI: 37.5,
41.7) for sub-chronic constipation. None of the simple definitions were adequate compared to the Rome III criteria.
Self-reported constipation over the past 12 months had the highest sensitivity (91.1%, 95%CI: 88.8, 93.4) and
negative predictive value (94.5%, 95%CI: 93.1, 96.1) compared to the Rome III criteria for chronic constipation but an
unacceptably low specificity (51.3%, 95%CI: 48.8, 53.8) and positive predictive value (37.1%, 95%CI: 34.4, 39.9).
Conclusions: The definition used to identify constipation within a population has a considerable impact on the
prevalence estimate obtained. Simple definitions, commonly used in research, performed poorly compared with the
Rome III criteria. Studies estimating population prevalence of constipation should use definitions based on the
Rome criteria where possible.
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Introduction
Constipation is a common condition in the community
which represents a significant burden for both individ-
uals and health care systems [1]. For the individual, con-
stipation is associated with pain and symptoms which
negatively impact quality of life [2]. From the health care
system perspective, considerable costs are associated
with the diagnosis and treatment of constipation [3–7].
Since constipation is such a burden, it is important to
know its prevalence but estimating the prevalence of
constipation in the community can be challenging.
Three large systematic reviews including 50 epidemio-
logical studies of community-dwelling adult populations
have shown that the prevalence varies widely, with esti-
mates for constipation ranging from 2 to 35% [8–10].
This wide range may be in part due to differences in
populations, because of various factors such as age
groups, culture, diet and environment, but it may also
be due to differences in the way constipation was de-
fined in each study [8]. Although the Rome criteria have
been developed for use as a standard definition of
chronic constipation, most epidemiological studies have
used a variety of other definitions of constipation. The
various definitions used have included self-reported
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constipation or questions based on one or some of the
symptoms as detailed in the Rome criteria.
The Rome criteria comprise a set of clinical symptoms
which are internationally recognised as the gold standard
in the diagnosis of chronic constipation [11, 12]. These
criteria were first developed in 1994 (Rome I) and subse-
quently revised in 2000 (Rome II), 2006 (Rome III) and
2016 (Rome IV) [13]. Whilst useful in clinical research
and pharmaceutical trials, the Rome criteria have been
found cumbersome to use in clinical practice [13] and
have not always been used in epidemiological research
[14]. The majority of epidemiological studies have not
investigated chronic constipation and have instead used
simple definitions of constipation such as self-reported
constipation over a defined time period, or specific
symptoms, such as bowel motion frequency [8, 15].
It is not known to what extent the definition of consti-
pation impacts prevalence estimates and whether any of
these simple measures are valid alternatives to the Rome
criteria for estimating the prevalence of chronic consti-
pation. The aims of this study were to explore the im-
pact that different definitions used to identify individuals
with constipation have on population prevalence esti-
mates and to compare the performance of simple defini-
tions with the Rome III criteria.
Methods
This study compared the prevalence of constipation in the
study population using five simple definitions with the
prevalence estimated using the Rome III criteria. The sen-
sitivity, specificity and predictive values for each of the
simple definitions were determined using the Rome III
criteria as the gold standard for chronic constipation and
modified Rome III criteria for sub-chronic constipation.
Study population
Community-dwelling adults (aged 18 years and over) who
were registered with a market research company (Research
Now) in April 2015 were invited to participate in an online
questionnaire exploring constipation and laxative use. The
market research company received payment for the work
and ensured that the final sample was representative of the
Australian population with respect to gender, age and loca-
tion by state. Informed consent from all participants was
obtained prior to completion of the online questionnaire
and participants were paid a nominal fee by the market re-
search company as compensation for their time. Survey re-
sponses were confidential and the identity of the
participants was not revealed to the researchers.
Constipation definitions
Rome criteria
At the time that this survey was conducted (2015), the
current Rome criteria were Rome III (Table 1). Chronic
constipation was defined as meeting the Rome III cri-
teria i.e. two or more symptoms as outlined in Table 1
for the last 3 months, with onset of symptoms being at
least 6 months prior. A modification to the Rome III cri-
teria was recently proposed for the identification of
sub-chronic constipation whereby symptoms are
assessed over 3 months as per the definition of chronic
constipation but without the requirement for 6 months
onset of symptoms [16]. This definition of sub-chronic
constipation was also used since some simple definitions
are based on a time period of 3 months. Both of these
definitions were used as the gold standards in this study
i.e. Rome III criteria for chronic constipation and the
modified Rome III criteria for sub-chronic constipation.
In the online survey, validated questions regarding each of
the symptoms specified in the Rome III criteria were used to
determine chronic and sub-chronic constipation [11].
Simple definitions
A literature search was conducted to identify simple def-
initions other than the Rome criteria, which have been
used in studies reporting the prevalence of constipation.
Five simple definitions were identified: self-reported con-
stipation over the past 2 weeks, self-reported constipa-
tion over the past 3 months, self-reported constipation
over the past 12 months, fewer than 3 bowel motions
per week over the past 3 months and fewer than 3 bowel
motions per week over the past 12 months.
In the online survey, self-reported constipation over 2
weeks, 3 months or 12months was assessed using the
questions: “Have you felt constipated at any time during
the last 2 weeks (or 3 months or 12 months)?”. Constipa-
tion defined by fewer than 3 bowel motions per week over
3months was assessed using the question: “Over the last 3
months, do you often have fewer than 3 bowel movements
each week?”. Constipation defined by fewer than 3 bowel
motions per week over 12months was assessed using the
question: “In the last 12 months, how many bowel move-
ments did you usually have each week?”
Table 1 The Rome III diagnostic criteria for defining chronic
constipation
Rome III Diagnostic Criteria [11]
Diagnostic criteriaa
1. Must include two or more of the following:
a. Straining during at least 25% of defaecations
b. Lumpy or hard stools in at least 25% of defaecations
c. Sensation of incomplete evacuation for at least 25% of defaecations
d. Sensation of anorectal obstruction/blockage for at least 25% of
defaecations
e. Manual manoeuvres to facilitate at least 25% of defaecations
(e.g. digital evacuation, support of the pelvic floor)
f. Fewer than 3 defaecations per week.
2. Loose stools are rarely present without the use of laxatives
3. Insufficient criteria for irritable bowel syndrome
aCriteria fulfilled for the last 3 months with symptom onset at least 6 months
prior to diagnosis
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Sample size
Based on an estimated prevalence of 30% [17], a mini-
mum of 2000 participants were required to give a preva-
lence estimate within 2 percentage points using a 95%
confidence interval (Epi-Info Version 7, Centers for Dis-
ease Control & Prevention).
Analysis
Descriptive statistics were used to describe the study
population. Chi-squared testing was used to check the
representativity of the study population against the na-
tional population in terms of gender, age, and location.
The prevalence of constipation in the study population
was calculated for each definition as the number of indi-
viduals identified with constipation according to each
definition, divided by the number of individuals in the
study population.
To determine how well each definition performed at
identifying constipation compared with the gold stan-
dards, the sensitivity, specificity, positive predictive value
(PPV) and negative predictive value (NPV) were calcu-
lated for each simple definition using the Rome III criteria
(chronic constipation) and modified Rome III criteria
(sub-chronic constipation) as the gold standards. Sensitiv-
ity was calculated as the proportion of participants who
were considered “constipated” by the simple definition out
of those considered “constipated” by the gold standard.
Specificity was determined as the proportion of partici-
pants who were considered “not constipated” according to
the test definition out of those considered “not consti-
pated” by the gold standard. The positive predictive value
(PPV) was calculated as the proportion of participants
considered “constipated” by the gold standard out of those
considered “constipated” by the simple definition and the
negative predictive value (NPV), the proportion of partici-
pants considered “not constipated” by the gold standard
out of those participants considered “not constipated” by
the simple definition [18].
A simple definition that could substitute for the Rome
III criteria would have high values for sensitivity, specifi-
city, PPV and NPV. Ideally each value should be close to
100% indicating that the definition is correctly identify-
ing those with and without constipation according to the
gold standard [19].
All statistical analysis was conducted using IBM SPSS
Statistics (Version 22, IBM Corporation).
Results
Study population
The market research company invited 29,174
community-dwelling adults to participate in the online sur-
vey and the questionnaire was completed by 2376 (8.1%)
respondents. After elimination of incorrectly completed
questionnaires, the study population comprised 2024
participants. Participants were representative of the Austra-
lian community-dwelling adult population in terms of gen-
der, age and location (Table 2). Half of the study population
were aged over 45 years (50.6%) and half (50.7%) were fe-
male. In the past year, 13% of the study population had
consulted a health care professional regarding constipation
and 37% had used one or more laxatives.
Prevalence
Using the Rome III criteria, 24.0% of the study population
had chronic constipation and 39.6% had sub-chronic con-
stipation (Table 3). Using the simple definitions, the preva-
lence estimates varied six-fold, from 9.4% using “fewer
than 3 bowel motions per week in the past 12 months” to
58.9% with “self-reported constipation in the past 12
months”. The prevalence estimate using “self-reported con-
stipation in the past 2 weeks” (24.9%, 95% CI 22.9–26.8)
was comparable to that that obtained by the Rome III cri-
teria for chronic constipation (24.0%, 95% CI 22.1–25.9).
Table 2 Study population characteristics (n = 2024)







Gender: Female 50.7% (1027) 50.6% 1
Age (years): 0.999
18–24 12.4% (250) 12.4%
25–34 17.8% (361) 18.2%
35–44 17.6% (357) 18.8%
45–54 18.5% (374) 18.1%
55–64 14.6% (296) 15.3%
65+ 19.1% (386) 17.2%
Location (state): 0.999
NSW 30.9% (627) 32.0%
Vic 24.9% (504) 24.9%
Qld 20.9% (423) 20.1%
SA 8.1% (163) 7.2%
WA 10.0% (203) 11.0%
Tas 2.1% (42) 2.2%
NT 0.9% (19) 1.0%










Laxative usec 36.9% (747)
aIBS Irritable bowel syndrome (medically diagnosed) bHCP Health care
professional cIn last 12 months
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The most common Rome III criteria symptoms re-
ported by participants were straining, hard stools and a
feeling of incomplete evacuation of stools, each of which
were reported by approximately 80% of those with
chronic constipation (Table 4). The least common symp-
tom was the need for manual manoeuvres to assist
defaecation. Approximately 40% of participants with
chronic or sub-chronic constipation reported having
fewer than 3 bowel motions per week.
Performance of simple definitions
No simple definition met our criteria for substitution of
the Rome III criteria for either chronic or sub-chronic
constipation i.e. none of the definitions had high enough
values for sensitivity, specificity, PPV and NPV (Table 5).
The simple definition with the highest sensitivity for
identifying both chronic and sub-chronic constipation
was “self-reported constipation over past 12 months”.
This definition identified 91% of individuals who were
considered to have chronic constipation according to
the Rome III criteria. While the sensitivity of this defin-
ition was high, the specificity was much lower (51%) in-
dicating that the definition incorrectly classified 49% of
participants who were not constipated according to the
Rome III criteria as being constipated. The PPV for this
definition was 37%, finding that of all the participants
considered constipated by this definition, only 37% were
also considered constipated by the gold standard (Rome
III). Similarly, for sub-chronic constipation, this defin-
ition correctly identified 84% of individuals but it had
the lowest specificity (58%) and lowest PPV (57%) of any
of the simple definitions when tested against the modi-
fied Rome III criteria.
The two simple definitions based on fewer than three
bowel motions per week had high specificities, i.e. they
correctly identified most participants who were not con-
stipated using both the Rome III and modified Rome III
criteria. However, the sensitivities associated with these
definitions were very low (17 to 46%), showing that these
definitions were unable to identify all of those consti-
pated according to the Rome III criteria.
Discussion
This study found that the definition of constipation used
to estimate prevalence has considerable impact on the
estimates of prevalence obtained. We found six-fold dif-
ferences in the prevalence of constipation estimated
using different definitions. Using the Rome III criteria in
a large nationally representative sample of
community-dwelling adults, we estimate that one in four
adults is chronically constipated. None of the simple def-
initions tested in this study performed well enough in
terms of sensitivity, specificity, PPV and NPV to be con-
sidered as suitable proxies for definitions of chronic or
sub-chronic constipation based on the Rome III criteria.
Using the Rome III criteria, we estimated the preva-
lence of chronic constipation in the Australian
community-dwelling adult population to be 24.0%. Pre-
vious studies have estimated the prevalence of chronic
constipation among Australian adults to range from 2.8
to 30.7% [16, 17, 20–23]. Different definitions used in
these studies may be the most important factor contrib-
uting to the wide range, however, differences in sample
populations, sample sizes and data collection methods
may also be relevant. Our survey was conducted online
with a large nationally representative sample, whereas all
previous Australian studies were mail surveys focussed
Table 3 Impact of constipation definition on prevalence estimate
Definition % Prevalence estimate
(95% Confidence interval)
Chronic constipation (Rome III criteria) 24.0 (22.1, 25.9)
Sub-chronic constipation
(modified Rome III criteria)
39.6 (37.5, 41.7)
Self-reported constipation in the
past 2 weeks
24.9 (22.9, 26.8)
Self-reported constipation in the
past 3 months
29.2 (27.2, 31.2)
Self-reported constipation in the
past 12 months
58.9 (56.8, 61.0)
Fewer than 3 bowel motions per
week in the past 3 months
19.6 (17.9, 21.3)
Fewer than 3 bowel motions per
week in the past 12 months
9.4 (8.1, 10.7)
Table 4 Prevalence of symptoms associated with constipation as per the Rome III criteria
Symptom All participants
(n = 2024)
Participants with chronic constipation
according to the Rome III criteria
(n = 485)
Participants with sub-chronic constipation
according to the modified Rome III criteria
(n = 801)
Fewer than 3 bowel motions per week 19.6% (397) 46.2% (224) 42.1% (337)
Straining 29.2% (590) 79.2% (384) 70.8% (567)
Hard stools 36.8% (744) 78.8% (382) 75.8% (607)
Incomplete evacuation 38.4% (778) 82.9% (402) 77.3% (619)
Perceived blockage 22.5% (457) 64.1% (311) 55.8% (447)
Manual manoeuvres 11.0% (222) 35.5% (172) 26.2% (210)
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on participants from certain geographical regions within
Australia which were unlikely to be representative of the
national population.
Although it is frequently difficult to achieve both high
sensitivity and high specificity when testing against a gold
standard [18], none of the commonly used simple defini-
tions tested in our study adequately identified individuals
with constipation compared with the Rome III criteria for
either chronic or sub-chronic constipation. To some ex-
tent this might have been expected since we compared
very simple definitions with a more complex definition as
the gold standard but use of sensitivity, specificity, positive
and negative predictive values is the appropriate method
to quantify the accuracy of alternative diagnostic tests
against a definitive gold standard diagnostic test [18]. We
observed considerable variation in prevalence estimates
with the different constipation definitions which indicates
that differences in the way constipation is defined may ex-
plain the wide variation in the prevalence of constipation
reported in the literature [8–10]. It also illustrates the im-
portance of using a suitable definition to identify individ-
uals with constipation when conducting prevalence
studies. The diversity of estimates of constipation preva-
lence in the Australian community further illustrates the
issue of different results obtained in different studies with
different definitions of constipation.
When considering the prevalence of individual symp-
toms, the most common symptoms were straining, hard
stools and incomplete evacuation which have similarly
been reported as the three most common core symp-
toms of constipation in other studies [24]. Only 42 to
46% of participants who were regarded as constipated
(sub-chronic or chronic) by the Rome III criteria re-
ported experiencing fewer than 3 bowel motions per
week. Also, less than 20% of all participants reported
fewer than 3 bowel motions per week yet almost 60%
had self-reported constipation in the last 12 months.
Similar findings have been reported in Japan where 28%
of participants in an online survey considered them-
selves to be constipated, but only 8% reported a bowel
motion frequency of fewer than 3 per week [25]. In our
study, simple definitions for identifying constipation
which used bowel motion frequency performed poorly
against the Rome III criteria, demonstrating that bowel
motion frequency should not be used to identify consti-
pation, unless used as one of the symptoms of the Rome
criteria.
Other research has found that estimates of prevalence
using self-reported constipation are greater than preva-
lence figures for chronic constipation derived from Rome
criteria in the same population [26–29]. We found that
self-reported constipation over 2 weeks approximated the
Table 5 Sensitivity, specificity, positive and negative predictive values for the five simple definitions compared to the Rome III
criteria and modified Rome III criteria as gold standards













over past 2 weeks
64.5% (60.2, 68.7) 87.7% (85.9, 89.2) 62.2% (57.9, 66.4) 88.7% (87.0, 90.2)
Self-reported constipation
over past 3 months
72.0% (67.8, 75.8) 84.3% (82.4, 86.1) 59.2% (55.1, 63.0) 90.5% (88.9, 91.9)
Self-reported constipation
over past 12 months
91.1% (88.8, 93.4) 51.3% (48.8, 53.8) 37.1% (34.4, 39.9) 94.5% (93.1, 96.1)
Fewer than 3 bowel
motions per week
over past 3 months
46.2% (41.8, 50.6) 88.8% (87.1, 90.2) 56.4% (51.5, 61.2) 84.0% (82.1, 85.7)
Fewer than 3 bowel
motions per week
over past 12 months
17.3% (14.2, 20.1) 93.0% (91.7, 94.2) 44.0% (37.1, 51.1) 78.1% (76.2, 80.0)
Sub-chronic constipation
(modified Rome III criteria)
Self-reported constipation
over past 2 weeks
50.6% (47.1, 54.0) 92.0% (90.3, 93.4) 80.5% (76.8, 83.7) 39.6% (37.5, 41.7)
Self-reported constipation
over past 3 months
61.3% (57.9, 64.6) 91.9% (90.3, 93.3) 83.2% (80.0, 86.0) 78.4% (76.2, 80.4)
Self-reported constipation
over past 12 months
84.3% (81.6, 86.6) 57.7% (54.9, 60.5) 56.6% (53.8, 59.4) 84.9% (82.3, 87.1)
Fewer than 3 bowel
motions per week over
past 3 months
42.1% (38.7, 45.5) 95.1% (93.7, 96.2) 84.9% (81.0, 88.1) 71.5% (69.2, 73.6)
Fewer than 3 bowel
motions per week
over past 12 months
16.9% (14.4, 19.6) 95.4% (94.1, 96.5) 70.7% (63.9, 76.7) 63.7% (61.4, 65.8)
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Rome III prevalence estimate for chronic constipation.
However, importantly both the sensitivity and PPV of the
simple definition, “self-reported constipation in the past 2
weeks”, were low, indicating that this simple definition did
not identify the same individuals with constipation as
identified by the Rome III criteria. One factor to consider
is that self-reported constipation is any constipation expe-
rienced during the defined time period whereas unmodi-
fied Rome criteria provide an indication of chronic
constipation only. A further consideration is that with
self-reported constipation, constipation is self-defined and
consequently different individuals may have different per-
ceptions of constipation [8, 30, 31]. It could be argued that
this is the true definition of constipation which should be
used in clinical practice but in prevalence studies of any
constipation, our results suggest that defining constipation
as “self-reported constipation for the last 3 months” might
be considered as an alternative to other constipation defi-
nitions since it compared more favourably to the gold
standards for both chronic and sub-chronic constipation
than the other definitions in terms of sensitivity, specifi-
city, PPV and NPV.
Our study showed that the period of time used in the
simple definitions affected the estimated prevalence. Look-
ing at the three definitions using self-reported constipa-
tion, as the time period increased the estimated
prevalence also increased, as might be expected in any es-
timate of period prevalence [32]. Also, the time periods
which have been used with self-reported constipation
often differ to the periods specified in the Rome criteria.
Many international epidemiological studies have used
self-reported constipation over 12months as the definition
of any constipation but our results indicate that this may
over-estimate the prevalence of constipation.
A major strength of our study is that it was conducted
in a large population-based sample which was nationally
representative in terms of age, gender and location of the
Australian community-dwelling adult population. One
limitation of our study was that although we asked if par-
ticipants had been medically diagnosed with irritable
bowel syndrome (IBS), we did not include questions re-
garding the Rome III diagnostic criteria for IBS. Conse-
quently, our estimated prevalence of 24.0% using the
Rome III criteria may include both functional constipation
and constipation due to IBS. This may be one reason why
our prevalence estimates for chronic and sub-chronic con-
stipation were much higher than the most recent study in
Australia where it was estimated that almost 4% of the
population may experience constipation-predominant IBS
[16]. Furthermore, it should be noted that, although our
survey was conducted prior to publication of Rome IV cri-
teria, the Rome IV criteria for functional constipation are
essentially the same as Rome III criteria. [14]. A further
limitation is the possibility that those with constipation
were more likely to complete the questionnaire resulting
in some selection bias which may in turn over-estimate
the prevalence.
Conclusion
This study highlights the importance of careful selection of
the definition since it has a major bearing on the estimated
prevalence of constipation. All of the simple definitions in-
cluded in this study are commonly used in research, yet
none provided a valid alternative to the Rome III criteria
which are considered to be the gold standard for diagnosis
of chronic constipation, or to the modified Rome III criteria
for diagnosis of sub-chronic constipation.
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